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Abstract
OBJECTIVES—To compare the long-term risk of repeat stress urinary incontinence (SUI)
surgery after different types of initial SUI surgery and to identify predictors of time to repeat SUI
surgery in a large, population-based cohort.
METHODS—We used de-identified, adjudicated health care claims data from approximately 100
employer-based plans across the United States from 2000 to 2009. We identified the index SUI
surgery in women aged 18 to 64 years. Kaplan-Meier survival curves were used to estimate
cumulative incidence of repeat surgery through 9 years. Cox proportional hazards models were
used to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for factors
associated with recurrent SUI surgery.
RESULTS—Over 10 years, we identified 155,458 eligible women who underwent one or more
SUI surgeries, with a total of 294,855 person-years of follow-up. Of these index surgeries,
127,848 (82.2%) were slings. The 9-year cumulative incidence of repeat surgery after any SUI
surgery was 14.5% (95% CI 13.4–15.5). As expected, bulking agents had the highest cumulative
incidence of repeat surgery (61.2%, 95% CI 56.3– 66.0) followed by needle suspension (22.2%,
95% CI 16.5–27.9); the lowest 9-year incidences were for Burch (10.8%, 95% CI 9.3–12.3) and
sling (13.0%, 95% CI 11.7–14.3). In a Cox proportional hazards model that adjusted for age, year
of index surgery, and region of the United States, the rate of repeat surgery was 28% higher for
slings compared with Burch (adjusted HR 1.28, 95% CI 1.19–1.37).
CONCLUSION—In this population-based analysis of women aged 18 to 64 years, Burch
procedures had the lowest 9-year cumulative incidence of repeat SUI surgery.
Surgical management of stress urinary incontinence (SUI) is common in the United States
with approximately 95,000 inpatient procedures1 and 105,500 outpatient procedures per
year.2 Numerous surgical procedures exist for the treatment of SUI. Historically, the gold
standard was the Burch colposuspension which was first introduced in 1961 and involves
supporting the anterior vaginal wall to Cooper ligament through a laparotomy incision.3,4
The midurethral mesh sling has now supplanted the Burch as the new standard. This shift
has occurred fairly rapidly given that the first midurethral sling, the tension-free vaginal tape
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(TVT), was approved by the U.S. Food and Drug Administration (FDA) just 14 years ago in
1998.5
One important factor that led to the wide adoption of the TVT was a randomized trial in
which 344 women with SUI were treated with either TVT or Burch and found to have
comparable long-term cure and complication rates.6,7 Furthermore, the minimally invasive
midurethral sling has the advantages of shorter operative times, technical ease, and the
ability to be performed on an outpatient basis, all of which have added to the popularity of
this procedure.
Existing literature suggests that the overall risk of reoperation after an initial SUI surgery is
approximately 8%–9%.8,9 However, when estimating the risk of repeat SUI surgery based
on the type of initial surgery, there have been conflicting results. Fialkow et al found that the
sling had a higher rate of reoperation compared with the Burch colposuspension.8 In
contrast, Abdel-Fattah et al reported higher rates of repeat SUI surgery after Burch.9 Thus, it
is unclear which procedure is associated with higher rates of repeat SUI surgery. Even fewer
data are available regarding the risk of repeat surgery after other types of SUI procedures.
Furthermore, limited data exist regarding differences in the risk of reopera-tion for SUI
based on age, region of the United States, or the year in which the initial surgery was
performed.
Given the limitations in the existing literature, the primary objective of this study is to use a
large health care claims database to estimate the long-term rate of reoperation for SUI after
an initial SUI surgery. Our secondary objective was to identify predictors of time to repeat
SUI surgery in a large, population-based cohort.
MATERIALS AND METHODS
We used the Thomson Reuters MarketScan Commercial Claims and Encounters database
(health care claims database) from 2000 to 2009.10 This database contains de-identified,
individual-specific clinical utilization and enrollment claims data for inpatient and outpatient
visits from approximately 100 employer-based plans in the United States. These de-
identified data represent the medical experience of privately insured employees, their
spouses, and their dependents until the age of 65, when they become eligible for Medicare.
This database has been rigorously evaluated and is valid and reliable.11 Furthermore, the
weighted data are representative of the younger, non-Medicare, privately insured U.S.
population in terms of sex, age, and region,12 and unique individuals can be tracked
longitudinally using encrypted identification numbers. This database provides information
on approximately 3.7 million individuals from 2000 and increases to 40.0 million
individuals by 2009. This study was determined to be exempt from further review by the
Institutional Review Board at the University of North Carolina at Chapel Hill.
The population at risk included all women aged 18 to 64 years from 2000 to 2009. All SUI
procedures among eligible women were identified based on the following Physicians’
Current Procedural Terminology Coding System, 4th edition (CPT) codes: 57288 for sling;
51840, 51841, or 51851 for Burch colposuspension; 51715 for endoscopic injection of
implant material into the submucosal tissue of the urethra, which we will refer to as “bulking
agents”; 57220 for Kelly plication; 51845 or 57289 for needle suspension; 51990 or 51992
for laparoscopic urethral suspension or laparoscopic sling operation, respectively, which is
referred to as “laparoscopic”; and 58267 or 58293 for total vaginal hysterectomy with colpo-
urethrocystopexy.
After capturing all SUI procedures, the first, or index, SUI surgery for each woman was
identified. We included women with at least 90 days of prior enrollment who did not have
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any gaps in coverage. Those with a diagnosis of a urethral diverticulum (International
Classification of Diseases, 9th Revision code 619.0) or any urinary– genital tract fistula
(International Classification of Diseases, 9th Revision codes 599.1 and 599.2) in the 90 days
before the index surgery were excluded. If both an inpatient and outpatient procedure claim
occurred on the same service date, we preferentially included the inpatient procedure. In
addition, if two or more procedure codes were observed on the same index date of surgery,
the primary procedure for the index SUI surgery was assigned using a hierarchy which
generally reflects decreasing degree of invasiveness: 1) Burch followed by 2) laparoscopic
SUI procedure, 3) total vaginal hysterectomy with colpo-urethrocystopexy, 4) sling, 5)
needle suspension, 6) bulking agent, and 7) Kelly plication.
To evaluate the long-term outcomes after SUI surgery, we estimated the cumulative
incidence of repeat SUI surgery stratified by the type of index surgery. Repeat SUI surgery
was defined as any subsequent SUI surgery. In this analysis, we did not include sling
revision or removal (CPT 57287) as we were focused on repeat surgery for the treatment of
SUI. We estimated the cumulative incidence and 95% confidence intervals (CIs) of repeat
SUI surgery annually through 9 years of follow-up for each type of index surgery. We also
assessed the following predictors for repeat surgery: age at the time of the index procedure
(18–34, 35– 44, 45–54, and 55– 64 years), geographic region (Northeast, Midwest, South,
West), and calendar year at the time of index procedure (2000–2009).
Descriptive statistics were used to characterize the population of women undergoing index
SUI surgery. Kaplan-Meier survival curves were used to estimate the cumulative incidence
of repeat SUI surgery annually for each year of follow-up, stratified by type of index
surgery. For the Kaplan-Meier analysis, a log-rank test was performed to assess differences
among the groups. We used Cox proportional hazards models to estimate the adjusted
hazard ratio (HR) of repeat surgery for each decade of increasing age at the time of the index
surgery compared with those 18 to 34 years, for calendar year at the time of the index
surgery relative to 2000, for region of the United States compared with the Northeast, and
for each type of procedure compared with the Burch. To further examine the changes over
time in the risk of repeat surgery for sling compared with Burch, we estimated separate
hazard ratios for each year of surgery. We also evaluated for possible interaction between
age and sling relative to Burch. We estimated 95% CIs on all effect estimates. Statistical
analyses were performed using SAS 9.2.
RESULTS
In this national database of privately insured individuals from 2000 to 2009, there were a
total of 32.9 million women aged 18 to 64 years. Of these women, 168,844 underwent one
or more SUI procedures, and for each of these women, we identified their first SUI surgery.
Among 155,458 women who met our inclusion criteria, the median age of women who
underwent an index SUI surgery was 49 years (interquartile range 43–56, range 18– 64).
Table 1 depicts the SUI surgery type-specific details regarding age, region, and calendar
year in which the surgery was performed. Patients who had a Burch were nearly 2 years
older, on average, than those who had a sling (median age 47.1 compared with 49.0 years).
The median year of the index procedure was 2007 (interquartile range 2005–2008). The
median length of follow-up after the index procedure was 1.3 years (interquartile range 0.5–
2.7 years, range 0–9.75 years), which represented a total of 294,855 person-years. The
median length of follow-up was not longer because the database includes many more
individuals in recent years and, thus, the majority of SUI surgeries included in the analysis
occurred during those years. For example, 3.7 million individuals were in the database in
2000 compared with 40.0 million in 2009. Thus, the opportunity to follow up women before
administrative censoring on December 31, 2009, was shortened and this decreased the
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overall median length of follow-up. The cumulative incidence of repeat SUI surgery for all
types of surgery at 9 years of follow-up was 14.5% (95% CI 13.4–15.5). The type of repeat
surgery performed was sling (70.5%) followed by bulking agents (20.1%), Burch (6.5%),
laparoscopic (1.5%), needle (0.8%), total vaginal hysterectomy (0.5%), and Kelly (0.2%).
Table 2 depicts the rate of repeat surgery for each year after the index surgery, stratified by
type of index procedure. As expected, bulking agents had the highest incidence of repeat
surgery followed by needle suspension; the Burch procedure had the lowest incidence,
which was 10.8% (95% CI 9.3–12.3) at 9 years of follow-up. Kaplan-Meier survival curves
depict the cumulative proportion of patients who underwent repeat SUI surgery over time
and accounts for the fact that not all patients were followed for the full 9 years (Fig. 1). The
Kaplan-Meier survival analysis demonstrates that there is a statistically significant
difference among the groups (P<.001). Because the rate of repeat surgery for bulking agents
was so high, we also estimated the incidence of repeat surgery after excluding this
procedure. With bulking agents excluded, the cumulative incidence of repeat SUI surgery
remained unchanged at 14.5% (95% CI 13.4–15.5), which reflects the fact that bulking
agents represented only a small fraction of the total number of surgeries.
To assess predictors of repeat surgery, we performed a Cox proportional hazards model and
evaluated age, calendar year when the index surgery was performed, region of the United
States, and type of index SUI procedure (Table 3). Women aged 35 to 44 years and 45 to 54
years did not have a significant difference in rate of repeat surgery compared with women
aged 18 to 34 years. However, women aged 55 to 64 years had a 14% higher rate of repeat
surgery compared with women aged 18 to 34 years (adjusted HR 1.14, 95% CI 1.04–1.25).
Compared with women who had the index surgery in 2000, the rate of repeat surgery was
significantly lower in all subsequent years (2001–2009). When compared with the Northeast
region of the United States, the rate of repeat surgery was elevated in the South (adjusted
HR 1.66, 95% CI 1.52–1.82) and in the West (adjusted HR 1.24, 95% CI 1.12–1.38) but was
not significantly different in the Midwest (adjusted HR 1.06, 95% CI 0.96–1.17).
After adjusting for age, calendar year of index surgery, and region, the rate of repeat surgery
was 8-fold higher for bulking agents (adjusted HR 8.19, 95% CI 7.53–8.90) compared with
Burch. For slings, the rate of repeat surgery was 28% higher than the rate for Burch
procedures (adjusted HR 1.28, 95% CI 1.19–1.37). Needle suspensions and laparoscopic
SUI surgeries also had significantly higher rates of repeat surgery compared with the Burch,
whereas the Kelly plication and total vaginal hysterectomy plus colpo-urethrocystopexy
were not significantly different (Table 3). Notably, the total number of Kelly plications was
quite low (less than 0.3% of the total procedures), and therefore, we were limited in our
ability to detect a statistically significant difference between this procedure and the Burch.
The CPT code for slings (57288) does not distinguish between a midurethral sling compared
with traditional bladder neck sling. Because a bladder neck sling is less likely to be
performed on an outpatient basis, we conducted a subgroup analysis limited to outpatient
slings to better assess the outcomes of midurethral slings in particular. Overall, 66.4% of
slings were performed on an outpatient basis. In an adjusted Cox proportional hazards
model, the rate of repeat surgery remained elevated when we compared outpatient slings to
the Burch (both inpatient and outpatient) (adjusted HR 1.50, 95% CI 1.40–1.61).
Because midurethral slings were relatively recently FDA-approved in 19985 and have
become the most common procedure performed, we wanted to focus on the relative rate of
repeat surgery between the sling and the Burch, the previous gold standard. In the adjusted
Cox proportional hazards model, the rate of repeat surgery was higher, on average, for slings
compared with Burch (Table 3). However, this estimate assumes that any difference in long-
term outcomes is the same regardless of the calendar year in which the procedure was
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performed. In other words, this model includes the main effects for calendar year and type of
procedure, but does not allow for an interaction between calendar year and type of
procedure. In a sensitivity analysis, we included the necessary interaction terms to allow the
hazard ratio to vary by age and calendar year. None of the interaction terms for age were
statistically significant (P>.05). For calendar year, Figure 2 depicts the adjusted HR for sling
compared with Burch, separately for each calendar year at the time of the index surgery. In
2000 and 2001, the hazard rate was lower for sling than Burch; however, between 2002 and
2009, the hazard rate was significantly higher for sling than Burch, meaning that the rate of
repeat surgery was significantly higher for women who had a sling in any year from 2002 to
2009 compared with women who had a Burch in that same time period.
DISCUSSION
In this population-based analysis of women aged 18 to 64 years, the cumulative incidence of
repeat SUI surgery after 9 years of follow-up was 14.5%. We confirmed that less effective
SUI surgeries, such as bulking agents13 and needle suspension,14 have higher rates of repeat
surgery. The Burch colposuspension had the lowest rate of repeat surgery for stress
incontinence. Of note, the rate of repeat SUI surgery after sling was 28% higher when
compared with the Burch procedure, and this difference was not explained by differences in
age or region of the United States. Furthermore, this difference was apparent every year
from 2002 to 2009, and thus, it is unlikely to be related to the initial learning curve for the
midurethral sling, which was FDA-approved in 1998.5
Both Burch and sling have been shown to be effective in the treatment of SUI7,15,16 but
prior observational studies have reported conflicting results regarding whether the Burch or
sling has a higher rate of repeat surgery. An analysis of 762 women in the United Kingdom
found an overall reoperation rate of 8.8% after SUI surgery. In this cohort, the risk of repeat
SUI surgery was 3.2% (11/342) for midurethral slings and 10.7% (34/319) for abdominal
retropubic procedures.9 In contrast, Fialkow et al evaluated over 41,000 women from
Washington state and found that women who received a sling had a higher reoperation rate
than those who underwent a Burch (6.7 compared with 4.2 per 1,000 person-years).8 Our
findings are similar to those of Fialkow et al. Furthermore, our study evaluates a larger
number of procedures (N=155,458) than previous studies and provides long-term,
population-based data regarding the risk of reoperation after an initial SUI surgery.
In our analysis, we were able to explore some factors that affect the risk of repeat surgery.
Our data are consistent with other studies demonstrating regional variations in rates of
surgical procedures for urinary incontinence. In particular, multiple studies have shown
lower rates of surgery for urinary incontinence in the Northeast.1,17 We also found that older
age was a risk factor for repeat surgery. Clark et al analyzed factors associated with
reoperation for pro-lapse and urinary incontinence; the authors did not find age to be
associated with repeat surgery among 36 out of 384 women who underwent reoperation.18
However, Richter et al found that women 65 years and older were more likely to undergo
surgical retreatment for SUI compared with younger women.19
The strengths of this study are related to the robust information in the database that we used.
Because this database represents a large population-based sample of privately insured
women across the United States, information from this database may be more generalizable
than data from a single, or even multiple, institutions. In addition, we were able to
longitudinally follow patients to assess the rate of repeat SUI surgery and to describe the risk
of reoperation based on type of the initial SUI procedure. Because we were able to account
for the specific time that each woman was enrolled in the database and to estimate individual
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person-time contribution, we were able to use survival time methods which allow us to
identify subsequent surgery for up to 9 years.
Although this database is reliable and valid, there are also several limitations of this data
source. Although we were strict in how we defined an index SUI surgery, we do not know if
these women had SUI surgery before enrollment into a contributing health plan. Because
this database is representative of younger, privately insured individuals, we cannot comment
on the relative rate of repeat surgery in elderly women aged 65 and older. This is an
important population as SUI surgery is more commonly performed in older women when
compared with women less than 65 years of age.1 We were also not able to report on other
potential risk factors for repeat surgery, such as race or ethnicity or body mass index, as
these characteristics are not captured in the database. In addition, we do not have
information regarding the severity of symptoms or what type of incontinence existed before
the index surgery, for example whether these women had pure stress incontinence compared
with mixed incontinence. There may also be other perioperative factors that influenced the
choice for regarding the type of index surgery performed and these factors may affect the
risk of repeat SUI surgery.
Another limitation is that we were unable to distinguish between midurethral mesh slings
compared with traditional bladder neck or pubovaginal slings, given that the CPT code
57288 does not indicate the type of sling performed. Furthermore, among the midurethral
slings, we cannot distinguish between the different types such as retropubic, transobturator,
or “mini-slings.” Thus, we cannot definitively state which type of sling is associated with a
higher risk of repeat SUI surgery. However, we know anecdotally that midurethral slings are
the predominant surgery for SUI. We attempted to explore this question by conducting a
subanalysis of outpatient slings, based on the premise that a bladder neck sling would be less
likely to be performed on an outpatient basis. When we focused on outpatient slings, the
Burch colposuspension continued to have a lower rate of repeat surgery.
In conclusion, we report that the cumulative rate of repeat SUI surgery was 14.5% (95% CI
13.4–15.5) at 9 years of follow-up and that the Burch colposus-pension had the lowest rate
of reoperation for SUI. Although we were able to explore age and region of the United
States as predictors for the rate of repeat SUI surgery, further research is needed to evaluate
other factors that may explain differences in the rate of repeat SUI surgery between the
Burch and sling. It is possible that differences in surgical skill among providers may explain
the lower rate of repeat surgery for the Burch. Alternatively, owing to the minimally
invasive nature of sling surgery, it is possible that surgeons may use less stringent criteria to
decide who should undergo a sling. In addition, surgeons may perform a sling in women
with mixed incontinence or urge incontinence or in women with other predisposing factors
for recurrent urinary incontinence. Given the magnitude of SUI surgeries performed in the
United States, it is critically important to evaluate the long-term outcomes of these
procedures and to specifically compare different types of SUI surgeries. Based on our data,
the Burch procedure remains an effective surgery for SUI with the lowest risk of reoperation
for stress incontinence in women aged 18 to 64 years.
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Kaplan-Meier survival curve after index stress urinary incontinence (SUI) surgery. This
survival curve depicts the cumulative incidence of repeat SUI surgery after each type of
procedure, and there is a statistically significant difference among the groups (P<.001). The
table lists the at-risk number remaining at the beginning (year 0) as well as at years 2, 4, 6,
and 8.
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The hazard ratio and confidence intervals of repeat surgery after sling compared with Burch
for each calendar year. The Y axis uses a logarithmic scale.
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Table 3
Cox Proportional Hazards Regression Analysis for Time to Repeat Stress Urinary Incontinence Surgery
Variable Adjusted Hazard Ratio (95% Confidence Interval) for Repeat Surgery
Age category (y)
 18–34 (reference) —
 35–44 0.95 (0.86–1.04)
 45–54 1.02 (0.93–1.12)
 55–64 1.14 (1.04–1.25)
Calendar year
 2000 (reference) —
 2001 0.71 (0.62–0.81)
 2002 0.42 (0.37–0.48)
 2003 0.43 (0.38–0.49)
 2004 0.42 (0.37–0.47)
 2005 0.50 (0.45–0.57)
 2006 0.43 (0.38–0.48)
 2007 0.41 (0.37–0.47)
 2008 0.49 (0.44–0.55)
 2009 0.56 (0.49–0.62)
Region of the United States
 Northeast (reference) —
 Midwest 1.06 (0.96–1.17)
 South 1.66 (1.52–1.82)
 West 1.24 (1.12–1.38)
 Unknown 1.73 (1.29–2.31)
SUI surgery type
 Burch (reference) —
 Sling 1.28 (1.19–1.37)
 Bulking agents 8.19 (7.53–8.90)
 Laparoscopic 1.29 (1.12–1.48)
 TVH and colpo-urethrocystopexy 1.18 (0.95–1.45)
 Needle suspension 1.75 (1.43–2.13)
 Kelly plication 1.15 (0.78–1.70)
SUI, stress urinary incontinence; TVH, total vaginal hysterectomy.
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